Advances in active surveillance of metastatic renal cell carcinoma
10.3760/cma.j.cn112330-20220707-00405
- VernacularTitle:转移性肾癌主动监测研究进展
- Author:
Zhili YAO
1
;
Keruo WANG
;
Gang LI
Author Information
1. 天津医科大学第二医院泌尿外科，天津 300211
- Keywords:
Carcinoma, renal cell;
Metastasis;
Active surveillance;
Treatment
- From:
Chinese Journal of Urology
2023;44(7):548-550
- CountryChina
- Language:Chinese
-
Abstract:
At present, systemic therapy is the main treatment option for metastatic renal cell carcinoma. However, active surveillance may be an alternative for patients with poor physical status or slow disease progression. Active surveillance can appropriately delay the timing of systematic treatment for some patients with metastatic renal cell carcinoma without affecting their prognosis. We have combined the latest researches to clarify the clinical significance, applicable population, disadvantages, scheme and prognosis of active surveillance in metastatic renal cell carcinoma in recent years in detail.
